JLS Fund II LP
Open, writing first checksEmerging manager
Open: first sale Dec 2023, per Form D (fund age approximates vintage)
- Vintage
- 2023
- Fund size
- $13.03M (Form D)
- Stages
- Not stated
- Sectors
- Biotech, Healthtech
- Regions
- Not stated
01 · Thesis
Finances and helps build companies that translate breakthroughs in neuroscience, technology, and data into patient outcomes and value for strategic acquirers. Portfolio spans psychedelic-assisted therapy, neuropsychiatric therapeutics, and psychiatric biotech.Inferred from the firm's website
02 · Initial check
$130K to $217K (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Lindsay Hoover, Managing partner
- Simeon Schnapper, Managing partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideWe finance and help build companies that translate breakthroughs in neuroscience, technology, and data into outcomes for patients—and value for strategic acquirers.
We finance and help build companies that translate breakthroughs in neuroscience, technology, and data into outcomes for patients—and value for strategic acquirers.
https://www.jls.fund/
06 · Sources
Last verified: Oct 28, 2026